- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Glabellar Crease
Total 10000 results
-
Zhiyong YuNot yet recruitingHER2-positive Advanced Breast Cancer
-
Shanghai Miracogen Inc.RecruitingAdvanced or Metastatic Breast CancerChina
-
Centre Georges Francois LeclercRecruiting
-
University Hospitals Bristol and Weston NHS Foundation...RecruitingHER2 Negative Metastatic Breast CancerUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingInvasive Breast Cancer | Post-mastectomyUnited States
-
European Organisation for Research and Treatment...Hellenic Oncology Research Group; Latin American Cooperative Oncology Group; Hellenic... and other collaboratorsActive, not recruitingBreast CancerUnited States, Ireland, United Kingdom, Belgium, Switzerland, Spain, Poland, Greece, Portugal, Egypt, Brazil, Netherlands, Peru, Serbia, Mexico, Sweden
-
MedSIRHoffmann-La RocheActive, not recruitingEarly Breast CancerSpain, Italy, Germany, Bulgaria, Hungary
-
H. Lee Moffitt Cancer Center and Research InstituteRegeneron PharmaceuticalsCompletedHormone Receptor-positive Breast CancerUnited States
-
Criterium, Inc.Novartis; Seagen Inc.Active, not recruitingHER2-positive Metastatic Breast CancerUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingBreast CancerUnited States, Puerto Rico
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.Active, not recruitingBreast Cancer | Hormone-receptor Positive Breast CancerChina
-
University of Illinois at ChicagoNational Cancer Institute (NCI)CompletedHigh Risk for Breast CancerUnited States
-
Sun Yat-sen UniversityCompletedHER2-negative Metastatic Breast CancerChina
-
Tata Memorial HospitalActive, not recruitingNon Metastatic Operable Breast CancerIndia
-
Istituto Romagnolo per lo Studio dei Tumori Dino...CompletedHER-2 Positive Breast CancerItaly
-
Ege UniversityEnrolling by invitationBreast Cancer | Health Behavior | Breast Self-ExaminationTurkey
-
Daiichi Sankyo Co., Ltd.Merck Sharp & Dohme LLC; Daiichi SankyoCompletedMetastatic Breast CancerUnited States, Japan
-
Washington University School of MedicineCompletedBreast Cancer Prevention | Mammographic DensityUnited States
-
GTxTerminatedMetastatic Breast CancerUnited States
-
Vastra Gotaland RegionCompletedChemotherapy Effect | Breast Cancer MetastaticSweden
-
Adlai Nortye Biopharma Co., Ltd.CompletedAdvanced or Metastatic Breast CancerChina
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); University of Rochester; University of Massachusetts...CompletedBreast Cancer | Breast Cancer Survivor | Fitness TrackersUnited States
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedER+ / HER2- Advanced Breast CancerChina
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedPhysical Activity | Breast Cancer FemaleUnited States
-
Consorzio OncotechCompleted
-
University Clinical Centre of KosovaCompletedBreast Cancer InvasiveKosovo
-
Roswell Park Cancer InstituteCompletedCancer Survivor | Invasive Breast CarcinomaUnited States
-
Zai Lab (Shanghai) Co., Ltd.CompletedHER2 Positive Metastatic Breast CancerChina
-
Odense University HospitalActive, not recruitingMetastatic Breast Cancer | Molecular ImagingDenmark
-
Novartis PharmaceuticalsCompletedAdvanced HER2-positive Breast CancerFrance, Italy, Germany, Singapore, Sweden, Spain, United Kingdom, United States
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)CompletedHealthy Subject | Female Breast CarcinomaUnited States
-
CelgeneTerminatedStage IV (Metastatic) Breast CancerUnited States
-
Universidad de Costa RicaUnknownMetastatic Breast Cancer | Mutation, PointCosta Rica
-
Weill Medical College of Cornell UniversityUniversity of California, Los AngelesCompleted
-
Fudan UniversityUnknownHER-2 Negative Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.UnknownHER2 Positive Metastatic Breast CancerChina
-
University of UtahCelgene CorporationTerminatedStages II-III Breast CancerUnited States
-
Genentech, Inc.No longer availableMetastatic Breast CancerUnited States
-
Instituto do Cancer do Estado de São PauloWithdrawnBreast Cancer | HER-2 Positive Breast CancerBrazil
-
Merrimack PharmaceuticalsCompletedHer2 Negative Breast Cancer PatientsUnited States, Spain, Canada, Germany, Russian Federation
-
Polaris GroupCompletedHER2 Negative Metastatic Breast CancerUnited States
-
Vector OncologyEisai Inc.TerminatedHER-2 Positive Breast CancerUnited States
-
Genentech, Inc.Completed
-
Memorial Sloan Kettering Cancer CenterQueens Health Network; CHARLES B WANG COMMUNITY HEALTH CENTER; Cancer Support...WithdrawnChinese Immigrants With Breast CancerUnited States
-
Hoffmann-La RocheRoche Pharma AGCompletedMetastatic Breast CancerItaly, Spain, Canada, United States, Belgium, France, Germany
-
AstraZenecaCompletedHormon Receptor Positive Breast CancerSerbia
-
National Cancer Institute (NCI)Active, not recruitingBreast Ductal Carcinoma In Situ | Invasive Breast Carcinoma | Multicentric Breast Carcinoma | Multifocal Breast Carcinoma | Synchronous Bilateral Breast CarcinomaUnited States, France, Spain, Canada, Saudi Arabia, Puerto Rico, Ireland, Mexico, South Korea, Colombia
-
National Cancer Institute (NCI)TerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
Xijing HospitalNot yet recruitingBreast Cancer | Serplulimab Combined With SHR-A1811 as Neoadjuvant Therapy for Triple-Negative Breast CancerChina